Cargando…

Demographic characteristics of children with early clinical manifestation of inflammatory bowel disease

INTRODUCTION: Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is a chronic condition of the colon and small intestine. The disease is common in young people (children and young adults), but it is rare in children younger than five years of age....

Descripción completa

Detalles Bibliográficos
Autores principales:	Szymańska, Edyta, Szymańska, Sylwia, Szczepański, Michał, Landowski, Piotr, Czaja-Bulsa, Grażyna, Jarocka-Cyrta, Elżbieta, Korczowski, Bartosz, Krzesiek, Elżbieta, Kierkuś, Jarosław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814533/ https://www.ncbi.nlm.nih.gov/pubmed/27110305 http://dx.doi.org/10.5114/pg.2015.52495

Ejemplares similares

Biological markers of disease activity in inflammatory bowel diseases
por: Szymanska, Edyta, et al.
Publicado: (2023)

Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn’s disease – a prospective multicentre trial
por: Matuszczyk, Małgorzata, et al.
Publicado: (2021)

The risk of cardiovascular complications in inflammatory bowel disease
por: Czubkowski, Piotr, et al.
Publicado: (2020)

Safety and Effectiveness of Vedolizumab for the Treatment of Pediatric Patients with Very Early Onset Inflammatory Bowel Diseases
por: Fabiszewska, Sylwia, et al.
Publicado: (2021)

Inflammatory bowel disease – one entity with many molecular faces
por: Szymańska, Sylwia, et al.
Publicado: (2019)

Endoscopic therapy of oesophageal strictures in children – a multicentre study
por: Pieczarkowski, Stanisław, et al.
Publicado: (2016)

Determinants of disease-specific knowledge among children with inflammatory bowel disease and their parents: A multicentre study
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2021)

Sexual functions in individuals with inflammatory bowel diseases
por: Kotkowicz-Szczur, Marta, et al.
Publicado: (2023)

Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study
por: Szymanska, Edyta, et al.
Publicado: (2021)

Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases—Correlation with Disease Activity and Fecal Calprotectin
por: Szymanska, Edyta, et al.
Publicado: (2021)

Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population
por: Ostrowski, Jerzy, et al.
Publicado: (2016)

The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn’s disease
por: Szymanska, Edyta, et al.
Publicado: (2016)

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
por: Szymanska, Edyta, et al.
Publicado: (2016)

Chronic Milk-Dependent Food Protein-Induced Enterocolitis Syndrome in Children from West Pomerania Region
por: Bulsa, Karolina, et al.
Publicado: (2021)

An irreducible left scrotal hernia containing a sigmoid colon tumor (adenocarcinoma) – Case report
por: Gnaś, Jarosław, et al.
Publicado: (2014)

The natural history of IgE mediated wheat allergy in children with dominant gastrointestinal symptoms
por: Czaja-Bulsa, Grażyna, et al.
Publicado: (2014)

What Do We Know Now about IgE-Mediated Wheat Allergy in Children?
por: Czaja-Bulsa, Grażyna, et al.
Publicado: (2017)

Adherence to Gluten-Free Diet in Children with Celiac Disease
por: Czaja-Bulsa, Grażyna, et al.
Publicado: (2018)

Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease
por: Szymanska, Edyta, et al.
Publicado: (2015)

Crosstalk between Resveratrol and Gut Barrier: A Review
por: Drabińska, Natalia, et al.
Publicado: (2022)

Food IgG(4) antibodies are elevated not only in children with wheat allergy but also in children with gastrointestinal diseases
por: Czaja-Bulsa, Grażyna, et al.
Publicado: (2016)

Virginal breast hypertrophy in a patient with Beckwith–Wiedemann syndrome
por: Szymańska, Edyta, et al.
Publicado: (2018)

Dermatological manifestations of the Coronavirus disease 2019 in children: a systemic review
por: Ciechanowicz, Piotr, et al.
Publicado: (2020)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Atherosclerotic Risk Factors in Children with Celiac Disease
por: Rybak, Anna, et al.
Publicado: (2020)

Cutaneous manifestations of coronavirus disease 2019 – review of literature and case reports
por: Ciechanowicz, Piotr, et al.
Publicado: (2020)

The effect of oligofructose-enriched inulin supplementation on gut microbiota, nutritional status and gastrointestinal symptoms in paediatric coeliac disease patients on a gluten-free diet: study protocol for a pilot randomized controlled trial
por: Krupa-Kozak, Urszula, et al.
Publicado: (2017)

Intestinal Permeability in Children with Celiac Disease after the Administration of Oligofructose-Enriched Inulin into a Gluten-Free Diet—Results of a Randomized, Placebo-Controlled, Pilot Trial
por: Drabińska, Natalia, et al.
Publicado: (2020)

Overview of the Importance of Biotics in Gut Barrier Integrity
por: Kocot, Aleksandra Maria, et al.
Publicado: (2022)

The Incidence of Inflammatory Bowel Disease in the Paediatric Population in the District of Lower Silesia, Poland
por: Krzesiek, Elzbieta, et al.
Publicado: (2021)

Variable clinical presentation of glycogen storage disease type IV: from severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities
por: Szymańska, Edyta, et al.
Publicado: (2017)

Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind study
por: Croft, Nicholas Michael, et al.
Publicado: (2023)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Beneficial Effect of Oligofructose-Enriched Inulin on Vitamin D and E Status in Children with Celiac Disease on a Long-Term Gluten-Free Diet: A Preliminary Randomized, Placebo-Controlled Nutritional Intervention Study
por: Drabińska, Natalia, et al.
Publicado: (2018)

A Randomized, Placebo-Controlled, Pilot Clinical Trial to Evaluate the Effect of Supplementation with Prebiotic Synergy 1 on Iron Homeostasis in Children and Adolescents with Celiac Disease Treated with a Gluten-Free Diet
por: Feruś, Klaudia, et al.
Publicado: (2018)

Plasma profile and urine excretion of amino acids in children with celiac disease on gluten-free diet after oligofructose-enriched inulin intervention: results of a randomised placebo-controlled pilot study
por: Drabińska, Natalia, et al.
Publicado: (2018)

TMPRSS6 rs855791 Polymorphism Status in Children with Celiac Disease and Anemia
por: Urbaszek, Klaudia, et al.
Publicado: (2021)

Comparison of novel markers of metabolic complications and cardiovascular risk factors between obese non-diabetic and obese type 1 diabetic children and young adults
por: Kącka, Anna, et al.
Publicado: (2022)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
por: Szymańska, Edyta, et al.
Publicado: (2020)

The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Gluten-Free Diet: Results of a Randomized, Placebo-Controlled Trial
por: Drabińska, Natalia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cmg7393h83onfdeko8c6u70n64